Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • aggp11
    Member
    • Jun 2011
    • 87

    #1

    DESeq2 for targeted RNA-Seq

    Hi,

    We plan to run some targeted whole transcriptome rna-seq using the AmpliSeq RNA methodology currently being sold by Life Technologies/Thermo Fisher. As a background on the technique, LT has designed 100-200bp probes for >20,800 features from RefSeq and provide that as a tool to study gene level differential expression. You can find more information here:



    I have been using DESeq2 for our whole transcriptome sequencing data and am wondering if DESeq2 will work for this targeted approach. I am reading/trying to understand more about the Math behind DESeq2 and on the surface it seems that DESeq2 should work fine because if I understand it correctly,"gene length" doesn't necessarily factor in the sizefactor based feature level normalization (unlike RPKM/FPKM, which in this case can be replaced by RPM/FPM). However, I am curious to know if I am overlooking something that might affect how DESeq2 would behave for such an experimental design.

    I'll appreciate any insights on this.

    Thank you!
  • Wolfgang Huber
    Senior Member
    • Aug 2009
    • 109

    #2
    Dear AGGP11,

    there is no fundamental reason why DESeq2 should not work with data from such an approach. As you say, the crucial assumption is that the number of reads for a gene is (to good enough approximation) proportional to its abundance, and that the proportionality factor -whatever it is- does not change between samples. So I'd make some exploratory plots to check whether this seems to be true for the data at hand.

    Wolfgang
    Wolfgang Huber
    EMBL

    Comment

    • aggp11
      Member
      • Jun 2011
      • 87

      #3
      Dear Wolfgang,

      Thank you for the response.

      Praful

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      33 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...